US allows emergency use of antiviral drug remdesivir to treat Covid-19 patients

UPDATED ON MAY 02, 2020 01:05 PM IST
The US has allowed the emergency use of the experimental antiviral drug remdesivir to treat Covid-19 based on early clinical data that shows it helps coronavirus disease patients recover faster. The antiviral drug remdesivir is made by Gilead Sciences and is the world's first drug approved based on clinical data to treat Covid-19, which has killed close to 240,000 people worldwide. Emergency-use authorization allows products to be used for treatment without full data on their safety and efficacy, which has to be still submitted as trials continue.
About The Video

The US has allowed the emergency use of the experimental antiviral drug remdesivir to treat Covid-19 based on early clinical data that shows it helps coronavirus disease patients recover faster. The antiviral drug remdesivir is made by Gilead Sciences and is the world's first drug approved based on clinical data to treat Covid-19, which has killed close to 240,000 people worldwide. Emergency-use authorization allows products to be used for treatment without full data on their safety and efficacy, which has to be still submitted as trials continue.

[RELATED VIDEOS]

Anti-coup protesters flash the three-fingered symbol of resistance while holding slogans bearing pictures of deposed leader Aung San Suu Kyi during a demonstration in Yangon.

Myanmar's Suu Kyi hit with new criminal charge

PUBLISHED ON APR 12, 2021 02:29 PM IST
SHARE
Story Saved